Document:

Exhibit
10.21

 

AMENDMENT
TO STOCKPURCHASE AGREEMENT

 

by
and among

 

LAWRENCE
PIZIK, RAAKHEE VYAS, WARREN PIZIK, DAVID SINGH, and

MATTHEW
REIK

 

and

 

PROGRESSIVE
CARE, INC.

 

dated
as of November 1, 2019

 

    	 

    	 

    

 

AMENDMENT
TO STOCK PURCHASE AGREEMENT

 

THIS
AMENDMENT TO STOCK PURCHASE AGREEMENT (the “Amendment”) is entered into as of  ,2019 (the “Effective
Date”) between PROGRESSIVE CARE, INC., a Delaware corporation (the “Purchaser”), and LAWRENCE
PIZIK, RAAKHEE VYAS, WARREN PIZIK, DAVID SINGH, and MATTHEW REIK (each individually a “Seller” and collectively
the “Sellers”) to amend certain of the terms for the purchase of 100% of the stock in FAMILY PHYSICIANS RX, INC.
d/b/a FIVE STAR RX, RX a Florida corporation (the “Corporation”) and amends that certain stock purchase
agreement by and among the Sellers and the Purchaser dated March 8, 2019, attached hereto as Exhibit A (the “Agreement”)
as follows.

 

Background
Statement

 

The
parties have had a dispute as to certain obligations under the Agreement and wish to resolve this dispute by amending the Agreement.
Under the Agreement, the Purchaser agreed to purchase 100% of the issued and outstanding shares of capita! stock of the Corporation under
the terms and conditions set forth in the Agreement. The Agreement required the Purchaser to pay certain amounts to Sellers and required
the Sellers to enter into employment agreements with the Purchaser. The parties, wishing to be released from certain obligations, have
agreed to a reduction in the purchase price as set forth in this Amendment and have agreed to a modification of the Employment Agreements.
Except as expressly modified by this Amendment, all other terms and conditions of the Agreement and each Employment Agreement with each
Seller shall remain in full force and effect. All express or implied agreements and understandings, either oral or written, heretofore
made with respect to the subject matter of this Amendment are expressly superseded by this Amendment. Capitalized terms used herein but
not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.

 

Statement
of Agreement

 

In
consideration of the premises, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree that the Agreement
is amended as follows:

 

1.
Section 2.2 of the Agreement. Section 2.2 of the Agreement is deleted in its entirety and replaced by the following provision:

 

Section
2.2 Purchase Price.

 

(a)
The purchase price paid by Purchaser for the Shares shall be One Million Nine-hundred thousand and No/100 Dollars ($1,900,000.00) (“Purchase
Price”).

 

(b)
Inventory Payment. The parties agree that the amount established by the parties as the fair market value for the inventory has
been paid by Purchasers to Sellers and no amount is owed by Purchaser for inventory. This amount was paid to Sellers on June 1, 2019.

 

    	 

    	 

    

 

(c)
Accounts Receivable Payment. The parties agree that no amount shall be payable to Sellers under Section 2.2(c) for Accounts Receivable
or any other amounts under this section. Purchaser will use the Accounts Receivable to reimburse payors identified by Sellers as having
claims reversed (approximately $200,000) and may retain the remainder.

 

	 	2.	Payment
    of Purchase Price. The parties acknowledge and agree that One Million Dollars ($1,000,000.00) of the Purchase Price was paid
    by Purchaser to Sellers in full on June 1, 2019. Purchaser agrees to pay Nine Hundred Thousand Dollars ($900,000.00) upon execution
    of this agreement, which shall be paid by joint written instruction from the parties to the Escrow Agent to Seller’s Counsel
    Escrow Account. Accordingly, once Purchaser pays the Nine Hundred Thousand Dollars ($900,000.00), no further payment obligations
    remain under the Agreement or otherwise from Purchaser to Sellers for any reason whatsoever.
	 	 	 
	 	3.	Termination
    of Escrow Agreement and Joint Instruction. The parties agree that the Escrow Agreement shall be terminated and that they shall
    execute the Termination of Escrow Agreement and Joint Instruction which shall be delivered to Purchaser at the Closing (as defined
    herein) in the form provided in Exhibit B.
	 	 	 
	 	4.	Rescission
    of Stock Issuance and Return of Stock Consideration. The parties acknowledge and agree that the issuance of Purchaser’s
    stock from Purchaser to Sellers is rescinded and the Stock Consideration that has been paid from Purchaser to Sellers pursuant to
    the Agreement shall be returned to Purchaser at the Closing. Purchaser transferred ten million (10,000,000) shares of common stock
    (“Shares”) in the Purchaser to Sellers at the June 1, 2019 closing. Sellers agree to the rescission and transfer
    of the ten million (10,000,000) shares of common stock back to Purchasers on the Closing Date.
	 	 	 
	 	5.	Amendment
    to Employment Agreements. The parties agree that each Employment Agreement that each Seller entered with Purchaser pursuant to
    the Purchase Agreement shall remain in effect. Section 6 of each employment agreement shall be amended as follows:

 

	 	 	b.	Termination
    without Cause. At any time during the Term, either party may terminate this Agreement immediately upon prior written notice to
    the other party. If an employee terminates without cause, he or she shall waive any claim or right that he or she may have now or
    in the future as to any rights or claims to employment and/or labor related compensation known or unknown, now or in the future (except
    for any accrued salary and benefits, including vacation pay or PTO, owed by Purchaser as of the date of termination). Purchaser shall
    pay compensation and benefits through the date of termination. If an Employee is terminated before November 30, 2019, Purchaser shall
    pay 4 weeks of severance pay. If an Employee is terminated after November 30, Purchaser shall pay up to 4 week severance pay, but
    such severance pay shall not extend the days’ paid past December 31, 2019 (for example, if an Employee was terminated on December
    27, 2019, such an Employee would only receive two days’ severance pay.

 

    	 

    	 

    

 

	 	6.	Non-Disparagement.
    Each party agrees to refrain from speaking disparagingly about the other and/or its subsidia1ies/affiliates, its officers, directors,
    members, employees, and agents to any client, vendor, customer, employee (both former and current), or any person both privately
    or publicly that could result in any harm to a party and/or its subsidiaries/affiliates.
	 	 	 
	 	7.	Tax
    Issues. Notwithstanding any other provision to the contrary in this Amendment and the Purchase and Sale Agreement, Purchase shall
    not amend any Corporation tax return for any tax period prior to the date of Closing unless requested in writing by a government
    entity such as the IRS or the SEC. Purchaser shall provide a copy of any such w1itten request to Seller’s counsel prior to
    any such amendment. As set forth in Paragraph 6.8 (a) Sellers shall file a tax return for the period from January 1, 2019 through
    the date of Closing and shall be responsible for any taxes for that period. As set fo1th in Paragraph 6.8(b) Purchaser shall be responsible
    to file any tax returns for the Corporation for the period from the date of Closing forward.
	 	 	 
	 	8.	Confidentiality
    of the Amendment. Without limitation, Section 6.7 of the Agreement shall also govern this Amendment.
	 	 	 
	 	9.	Closing.
    The execution of this Amendment shall take place at the Closing which shall occur electronically or at such place mutually agreed
    to in writing by all parties. The transfer of the Shares and the consummation of the other transactions contemplated by this Amendment
    (the “Closing” shall take place electronically on or before November 1, 2019 (the “Closing Date”),
    which date may be extended by mutual written agreement of the patties to this Agreement.
	 	 	 
	 	10.	Deliveries
    by the Sellers at Closing. At the Closing, the Sellers’ Representative shall deliver or cause to be delivered to Purchaser
    the following signed by each of the requisite Sellers and/or Sellers’ Representative, as applicable:

 

	 	 	a.	Stock
    ce1tificates representing the ten million (10,000,000) Shares in Purchaser owned by the Sellers, duly endorsed in blank or accompanied
    by stock powers duly executed in blank.
	 	 	 	 
	 	 	b.	A
    signed Termination of Escrow Agreement and Joint Instruction executed by each Seller in substantially the form provided in Exhibit
    B.

 

	 	1I.	Mutual
Waiver of Known Claims Related to Value of Corporation or Payment Under the Agreement. The parties intend to resolve all known issues
related to the value of the purchase of the Corporation by Purchaser and payment therefor to Sellers through the execution of this Amendment.
Sellers waive any known claim they have or may have had, against the Purchasers, and any affiliates, officers and directors of Purchasers
relating to the purchase price of the Corporation or payment therefor under the Agreement. Purchaser waives any known claims that Purchaser
has, or may have had, relating to the value of the Corporation for purposes of the Agreement, including the reversed claims in the amount
of approximately $200,000.00 and the fact that the Participating Provider Agreement with CVS/Caremark was terminated prior to closing.
	 	 	 
	 	11.	Amendment
    Effective Upon Payment. This Amendment shall be of no force and effect until the Payment of Nine Hundred Thousand and NO/100
    Dollars ($900,000.00) set forth in paragraph 2 is received by Seller’s Counsel.

 

    	 

    	 

    

 

	 	PURCHASER:
	 	 	 
	 	Progressive Care, Inc., a Delaware corporation
	 	 	 
	 	 	                                      
	 	Name:	Shital
    P. Mars
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	SELLERS:
	 	 	 
	 	 
	 	Lawrence
    Pizik
	 	 
	 	 
	 	Raakhee
    Vyas
	 	 
	 	 
	 	Warren
    Pizik
	 	 
	 	 
	 	David
    Singh
	 	 
	 	 
	 	Matthew
    Reik
	 	 
	 	 
	 	SELLERS’
    REPRESENTATIVE:
	 	 
	 	 
	 	Lawrence
    Pizik

 

    	 

    	 

    

 

EXHIBIT
A

Stock
Purchase Agreement

 

    	 

    	 

    

 

EXHIBIT
B

 

TERMINATION
OF ESCROW AGREEMENT AND JOINT INSTRUCTION

 

This
TERMINATION OF ESCROW AGREEMENT AND JOINT INSTRUCTION (this “Termination”) is entered into as of this_ day of October,
2019, by and among LAWRENCE PIZIK, RAAKHEE VYAS, WARREN PIZIK, DAYID SINGH, and MATIHEW REIK (each a “Seller” and, collectively,
the “Sellers”), PROGRESSIVE CARE, INC., a Delaware corporation (“Purchaser”), and HANSEN BLACK
ANDERSON ASHCRAFT PLLC, a Utah professional limited liability company (“Escrow Agent”). Each of Sellers and Purchaser
may be referred to individually as an “Escrow Party” and collectively as the “Escrow Parties”. Each
of Sellers, Purchaser, and Escrow Agent may be referred to individually as a “Party” or collectively as the “Parties”.

 

RECITALS:

 

A.
The Parties are parties to that certain Escrow Agreement entered into as of March 6, 2019 (“Escrow Agreement”),
under which the Purchaser deposited certain monies with the Escrow Agent.

 

B.
Under the Escrow Agreement, Pw-chaser initially deposited Two Million, Three Hundred Thousand and No/100 Dollars ($2,300,000.00) (“Initial
Funds”) to be held by Escrow Agent and distributed in accordance with the Escrow Agreement. Of the Initial Funds, One Million
and No/100 Dollars ($1,000,000.00) has been deposited to Sellers in accordance with the terms of the Escrow Agreement. One Million, Three
Hundred Thousand and No/100 Dollars ($1,300,000.00) (the “Remaining Funds”) remains in the escrow account controlled
by the Escrow Agent subject to the terms of the Escrow Agreement.

 

C.
The Escrow Parties have agreed to direct Escrow Agent to immediately release the Remaining Funds to Purchaser, as more particularly set
forth herein.

 

NOW
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as
follows:

 

1.
Recitals, Defined Terms. The above stated Recitals are true and correct and by this reference are incorporated herein. All capitalized
terms used herein that are not otherwise defined herein shall have the meanings ascribed to such te1ms in the Escrow Agreement.

 

2.
Termination. The Escrow Agreement is hereby terminated by mutual agreement of all Sellers and the Purchaser, and the Escrow Agreement
shall have no further force or effect.

 

3.
Release of Remaining Funds; Joint Written Instruction.

 

	 	a.	Release
    of Funds. The Escrow Parties hereby direct Escrow Agent to disburse the Remaining Funds to Purchaser in accordance with this Termination
    and the joint written instruction contained in Section 3(b).

 

    	 

    	 

    

 

	 	b.	Joint
    Written Instruction. In accordance with Section 3 of the Escrow Agreement, the Escrow Parties hereby jointly acknowledge that Nine
    Hundred Thousand and No/100 Dollars ($900,000.00) shall be wired immediately to Counsel for Sellers Escrow Accow1t:

 

Centennial
Bank:

 

[redacted]

[redacted]

Routing
Number [redacted]

 

For
Credit to:

 

Kevin
Patrick Donaghy, LLC Escrow Account

[redacted]

[redacted]

Account
Number [redacted]

 

	 		and
  the Remaining Funds, Four Hundred Thousand and No/00 Dollars ($400,000.00) should be distributed to Investor immediately upon
  receipt by Escrow Agent of this Termination.

 

	 	c.	Satisfaction
    of Obligations. Upon receipt by Purchaser of the Remaining Funds, the Escrow Agent’s responsibilities under the Escrow Agreement
    shall be deemed satisfied in full.

 

4.
Reservation of Rights. Termination of the Escrow Agreement and release of the Remaining Funds shall not constitute a waiver or release
by Purchaser of Sellers from any obligations or liability Purchaser would otherwise have under applicable laws, ordinances, codes or
regulations, including under common law relating to any agreement by and among the Escrow Parties.

 

5.
Successors and Assigns. The provisions of this Termination shall inure to the benefit of and be binding upon the heirs, successors and
assigns in interest of the parties hereto.

 

6.
Captions. The captions of the paragraphs of the Termination are solely for the convenience of the parties hereto, are not a part of this
Termination and will not be used for the interpretation of any provision of the Termination.

 

7.
Severability. If any provision of this Termination shall for any reason be held violative of any applicable law, governmental rule or
regulation, or if said agreement is held to be unenforceable or unconscionable, then the invalidity of such specific provisions herein
shall not be held to invalidate the remaining provisions of this Termination.

 

8.
Applicable Law. This Termination and its application will be governed by the laws of the State of Florida.

 

9.
Counterparts, Electronic Signature Pages. This Termination may be executed in any number of counterparts, each of which when so executed
and delivered shall be deemed an original and all of which taken together constitute but one and the same instrument. Electronic signature
pages, including facsimile and scanned counterpart signature pages, shall be deemed original signature pages for all purposes.

 

[The
remainder of this page is intentionally left blank]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above.

 

	 	SELLERS:
	 	 	 
	 	 
	 	Lawrence Pizik
	 	 	 
	 	 
	 	Raakhee Vyas
	 	 	 
	 	 
	 	Warren Pizik
	 	 	 
	 	 
	 	David Singh
	 	 	 
	 	 
	 	Matthew Reik
	 	 	 
	 	PURCHASER:
	 	 	 
	 	Progressive Care, Inc., a Delaware corporation
	 	 	 
	 	 
	 	Name:	Shital P. Mars
	 	 	 
	 	Title:	 Chief Executive Officer

 

	Agreed
    to and accepted by:	 
	 	 
	ESCROW
    AGENT:	 
	 	 
	HANSEN
    BLACK ANDERSON ASHCRAFT PLLC	 
	 	 	 
	By:		 
	 	Jonathan
K. Hansen, ManagerDocument

Exhibit 10.1

FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT
This First Amendment to Securities Purchase Agreement (this “First Amendment”) is entered into as of April 4, 2022 (the “First Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), Adjuvant Global Health Technology Fund, LP, and Adjuvant Global Health Technology Fund, DE, LP (the “Purchasers”).
RECITALS
WHEREAS, the Company and the Purchasers are party to that certain Securities Purchase Agreement, dated as of October 14, 2020 (the “Purchase Agreement”), pursuant to which the Purchasers purchased certain convertible promissory notes (the “Notes”; together with the Purchase Agreement , the “Transaction Documents”) of the Company;
WHEREAS, pursuant to Section 10.8 of the Purchase Agreement, any term of the Purchase Agreement or the Notes may be amended only with the written consent of the Company and the Purchasers holding a majority of the outstanding balance, in the aggregate, of all Notes issued pursuant to the Purchase Agreement (the “Requisite Purchasers”);
WHEREAS, the undersigned Purchasers constitute the Requisite Purchasers; and
WHEREAS, the Company and the Purchasers wish to amend the Purchase Agreement to address the provisions set forth herein effective as of the First Amendment Effective Date.
NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
AGREEMENT
1.    Definitions; References; Continuation of Purchase Agreement.  Unless otherwise specified herein, each capitalized term used herein that is defined in the Purchase Agreement shall have the meaning assigned to such term in the Purchase Agreement.  Each reference to “hereof,” “hereto,” “hereunder,” “herein” and “hereby” and each other similar reference, and each reference to “this Agreement”, the “Securities Purchase Agreement” and each other similar reference, contained in the Purchase Agreement and any other Transaction Document shall from and after the date hereof refer to the Purchase Agreement as amended hereby.  Except as amended or waived hereby, all terms and provisions of the Purchase Agreement and the Notes shall continue unmodified and remain in full force and effect.
2.    Amendment to the Purchase Agreement.
2.1    Amendment to Section 1.1 of the Purchase Agreement.  Effective as of the First Amendment Effective Date, Section 1.1 of the Purchase Agreement is hereby amended to add new defined terms “Financing,” “Qualified Financing Threshold,” and “Underwritten Financing” as set forth below:
“Financing” means any offering and sale by the Company of Equity Securities after the First Amendment Effective Date for the principal purpose of raising capital.
“Qualified Financing Threshold” means the closing of a single Underwritten Financing resulting in aggregate gross proceeds to the Company of at least $20,000,000.00.

“Reverse Split Effective Date” means the date of effectiveness of a reverse stock split of the Common Stock as described in that certain Definitive Proxy Statement of the Company filed with the SEC on March 30, 2022.
“Underwritten Financing” means any marketed and underwritten public offering and sale by the Company of Equity Securities after the First Amendment Effective Date for the principal purpose of raising capital.
2.2    Amendment to Section 4.1 of the Purchase Agreement.  Effective as of the Reverse Split Effective Date, the first paragraph of Section 4.1 of the Purchase Agreement is hereby deleted in its entirety and replaced with the following:
“Optional Conversion.  Subject to the limitations set forth in Sections 4.4 and 4.5, at the option of each Purchaser, each Purchaser shall have the right to convert all or any portion of the Notes held by such Purchaser at any time into Common Stock at a conversion price (the “Conversion Price”) equal to the lesser of (i) $0.36186 and (ii) 100% of the lowest price per share of Common Stock (or, as applicable with respect to any Equity Securities convertible into Common Stock, 100% of the applicable conversion price) which the Company sells securities in any Financing until the Company has met the Qualified Financing Threshold (including such Underwritten Financing that achieves the threshold).”
2.3    Amendment to Section 4.2 of the Purchase Agreement. Effective as of the achievement of the Qualified Financing Threshold, the first paragraph of Section 4.2 of the Purchase Agreement is hereby deleted in its entirety and replaced with the following:
“Automatic Conversion. The Outstanding Balance shall automatically convert into shares of Common Stock at the Conversion Price immediately following the earliest of (a) the time at which the 30-day VWAP of a share of the Common Stock is $10.00, or (b) the time at which the Company achieves cumulative net sales from the sales of Phexxi (determined in accordance with GAAP) of $100,000,000; provided, however, that clause (b) above be of no further force or effect as of and after July 1, 2023.”
2.4    Amendment to Section 7.1(e) of the Purchase Agreement.  Effective as of the achievement of the Qualified Financing Threshold, Section 7.1(e) of the Purchase Agreement is hereby deleted in its entirety and replaced with the following:
“by no later than June 30, 2023, the Company shall have recognized cumulative net sales from sales of Phexxi (determined in accordance with GAAP) of at least $100,000,000;”
3.    Miscellaneous.
3.1    Governing Law.  This First Amendment shall be governed in all respects by and construed in accordance with the laws of the State of New York without regard to provisions regarding choice of laws.
3.2    Entire Agreement.  This First Amendment, together with the Purchase Agreement, the Notes, the other Note Documents, and the Exhibits to the Purchase Agreement and thereto (all of which are hereby expressly incorporated herein by this reference) constitute the entire understanding and agreement between the parties with regard to the subjects hereof and thereof.
2

3.3    Titles and Subtitles.  The titles of the sections and clauses of this First Amendment are for convenience of reference only and are not to be considered in construing this First Amendment.
3.4    Counterparts.  This First Amendment may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument.  Delivery by facsimile or e-mail of an executed counterpart of a signature page shall be effective as delivery of an original executed counterpart.
3.5    Severability.  Should any provision of this First Amendment be determined to be illegal or unenforceable, such determination shall not affect the remaining provisions of this First Amendment.
[Signature page follows.]

3

IN WITNESS WHEREOF, the parties have executed this First Amendment to Securities Purchase Agreement to be effective as of the date first above written.
EVOFEM BIOSCIENCES, INC.

By:  /s/ Justin J. File
Name:  Justin J. File
Title:  Chief Financial Officer
Address:
12400 High Bluff Drive, Suite 600
San Diego, CA

Email: 

Signature Page to First Amendment to Securities Purchase Agreement

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, LP
as a Purchaser
By:  Adjuvant Capital GP, L.P., its General Partner
By:  Adjuvant Capital Management, LLC, its General Partner

By:  /s/ Jenny Yip
Name: Jenny Yip
Title: Co-President
Address:
445 Fifth Ave, #20D
New York, NY 10016

Email: 

Signature Page to First Amendment to Securities Purchase Agreement

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, LP,
as a Purchaser
By: Adjuvant Capital GP, L.P., its General Partner
By: Adjuvant Capital Management, LLC, its General Partner

By:  /s/ Jenny Yip
Name: Jenny Yip
Title: Co-President
Address:
445 Fifth Ave, #20D
New York, NY 10016

Email:  

Signature Page to First Amendment to Securities Purchase Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]